Collplant Biotechnologies' Cash And Cash Equivalents As Of June 30, 2024, Were $18.9M, Expected To Provide Cash Runway Into At Least Until The End Of 2025
Collplant Biotechnologies' Cash And Cash Equivalents As Of June 30, 2024, Were $18.9M, Expected To Provide Cash Runway Into At Least Until The End Of 2025
Collplant生物技術公司截至2024年6月30日的現金及現金等價物爲1890萬美元，預計能夠提供現金流到至少2025年底。
Collplant Biotechnologies' Cash And Cash Equivalents As Of June 30, 2024, Were $18.9M, Expected To Provide Cash Runway Into At Least Until The End Of 2025
Collplant生物技術公司截至2024年6月30日的現金及現金等價物爲1890萬美元，預計能夠提供現金流到至少2025年底。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間